NCT05647525View on ClinicalTrials.gov

The Etiology of New-onset Status Epilepticus

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

September 30, 2022

Conditions
Status Epilepticus
Interventions
DIAGNOSTIC_TEST

Perform autoimmune encephalitis titer tests

We only follow up without intervention.

Trial Locations (1)

Unknown

Jie Liu, Chengdu

All Listed Sponsors
lead

Jie Liu

OTHER

NCT05647525 - The Etiology of New-onset Status Epilepticus | Biotech Hunter | Biotech Hunter